when was glp-1 discovered Historical timeline of biology, receptor agonist discovery, and Oral Small-Molecule GLP-1 Receptor Agonists:

The synergistic effect makes combination therapy attractive for patients requiring stronger glycemic control who haven't achieved targets on monotherapy

Bariatric Surgery: Pros: Most effective for maximum, sustained weight loss and disease remission

#Diabetes #insulin #drugdiscovery #innovation #medicine #clinicaltrials #genetic #drugdevelopment #drugdelivery To view or add a comment, sign in GDF15, Omega-3s, and the "Apelin" Safety Switch Metforminthe worlds most famous longevity-adjacent drugworks largely by boosting GDF15 (Growth Differentiation Factor 15)

For example: Semaglutide for diabetes (Ozempic): Start at 0.25 mg weekly for 4 weeks, increase to 0.5 mg, then potentially to 1 mg or 2 mg at 4-week intervals Semaglutide for weight management (Wegovy): Start at 0.25 mg weekly, increasing through 0.5 mg, 1.0 mg, 1.7 mg to 2.4 mg at approximately 4-week intervals Liraglutide for weight management (Saxenda): Start at 0.6 mg daily, increasing by 0.6 mg increments weekly to a target of 3.0 mg daily This titration schedule is evidence-based and should not be accelerated without medical supervision

A secondary comparison examined the effects of medications approved for AUD, such as disulfiram, acamprosate, and naltrexone

[DOI] [PMC free article] [PubMed] [Google Scholar] 26